glp-1 peptide hormone Receptor Agonist Services for Type 2 Diabetes and Obesity Drug Development Targeting GLP-1, GIP & GCG
Description
Muscle Mass and Glucagon-like Peptide-1 Receptor Agonists: Adaptive or Maladaptive Response to Weight Loss? Circulation, vol
"For example, tracking changes in taste could help gauge whether the treatment is working beyond weight loss
Insulin secretion in type 1 diabetes
These drugs have also demonstrated beneficial effects for people with heart failure and chronic kidney disease with or without a T2DM diagnosis
A total of 112 articles were initially identified through comprehensive database searches
